乳腺外科
2019年度論文・学会発表

Tsuyuki S, Yamagami K, Yoshibayashi H, Sugie T, Mizuno Y, Tanaka S, Kato H, Okuno T, Ogura N, Yamashiro H, Takuwa H, Kikawa Y, Hashimoto T, Kato T, Takahara S, Katayama T, Yamauchi A, Inamoto T：Effectiveness and safety of surgical glove compression therapy as a prophylactic method against nanoparticle albumin−bound−paclitaxel−induced peripheral neuropathy. The Breast 2019；47：22−27.
Yamashiro H, Iwata H, Masuda N, Yamamoto N, Nishimura R, Ohtani S, Sato N, Takahashi M, Kamio T, Yamazaki K, Saito T, Kato M, Lee T, Kuroi K, Takano T, Yasuno S, Morita S, Ohno S, Toi M, JBCRG−C01 Collaborative Group：Outcomes of trastuzumab therapy in HER 2−positive early breast cancer patients：Extended follow−up of JBCRG−cohort study 01. Breast Cancer 2020；DOI：10.1007/s 12282−020−01057−4.
Ishii K, Morii N, Yamashiro H：Pertuzumab in the treatment of HER 2−positive breast cancer：An evidence−based review of its safety, efficacy, and place in therapy. Core Evidence 2019；14：51−70.

〈他施設との共同研究〉

丹羽幸司，織田裕行，石井慧，康純，諸富公昭，磯貝典孝：性同一性障害患者の受け入れについて―MTF（Male to Female）特性に基づく医療側の対応―．近畿大学医学雑誌 2019；44(1-2)：9-15．

〈他施設との共同研究〉

Kawaguchi K, Takada M, Kotake T, Yoshimura M, Uozumi R, Kataoka M, Koyama T, Tokumasu R,Honda M, Yamashita R, Yonezawa A, Himoto Y, Onishi N, Kato H, Yoshibayashi H, Suwa H, Tsuji W, Yamashiro H, Kataoka T, Ishiguro H, Parida L, Morita S, Toi M：Alteration of the tumor immune microenvironment signatures by nivolmab combined with radiation therapy for patients with metastatic breast cancer (Translational Research of the KBCRN−B−002 trial). San Antonio Breast Cancer Symposium, 2019.12.10, San Antonio, TX (USA)
Takada M, Yoshimura M, Kawaguchi K, Kotake T, Uozumi R, Kataoka M, Koyama T, Kato H, Yoshibayashi H, Suwa H, Tsuji W, Yamashiro H, Kataoka T, Ishiguro H, Tokumasu R, Honda M, Yamashita R, Yonezawa A, Himoto Y, Onishi N, Parida L, Morita S, Toi M：A multicenter phase Ⅰb/Ⅱ study for evaluating safety and efficacy of Nivolumab in combination with radiation therapy in patients with HER 2−negative metastatic breast cancer (KBCRN−B−002 trial). San Antonio Breast Cancer Symposium, 2019.12.10, San Antonio, TX (USA)

〈他施設との共同研究〉

唐宇飛，山本豊，山城大泰，近藤直人，中村力也，柏葉匡寛，高橋將人，津川浩一郎，石川孝，中山貴寛，大谷彰一郎，高野利実，藤澤知巳，遠山竜也，川口英俊，増野浩二郎，谷野裕一，森田智視，戸井雅和，大野真司，Japan Breast Cancer Research Group：HER2陰性進行再発乳癌に対するベバシズマブとパクリタキセル療法の前向き観察研究（JBCRG−C05試験 B−SHARE）．第27回日本乳癌学会学術総会，2019.7.13，東京

Ishii K, Morii N, Yamashiro H：Investigation of prognostic factors in breast cancer patients with brain metastases：A case series. 第57回日本癌治療学会学術集会，2019.10.26，博多（福岡）

乳腺外科2019年度 論文・学会発表